Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott.

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...

Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million.

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer.